Fiduciary Trust’s AbbVie ABBV Stock Holding History

Fiduciary Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.7M	Sell	311,267 -15,340	-5%	-$3.4M	0.8%	23
2025 Q4	$74.6M	Sell	326,607 -3,779	-1%	-$861K	0.85%	20
2025 Q3	$76.5M	Buy	330,386 +3,097	+0.9%	+$631K	0.87%	20
2025 Q2	$60.8M	Sell	327,289 -1,267	-0.4%	-$235K	0.75%	23
2025 Q1	$68.8M	Buy	328,556 +25,277	+8%	+$4.91M	0.9%	20
2024 Q4	$53.9M	Buy	303,279 +3,674	+1%	+$675K	0.71%	24
2024 Q3	$59.2M	Sell	299,605 -330	-0.1%	-$61.6K	0.83%	24
2024 Q2	$51.4M	Sell	299,935 -1,581	-0.5%	-$262K	0.77%	24
2024 Q1	$54.9M	Buy	301,516 +1,185	+0.4%	+$204K	0.84%	20
2023 Q4	$46.5M	Sell	300,331 -8,454	-3%	-$1.23M	0.78%	26
2023 Q3	$46M	Sell	308,785 -4,254	-1%	-$624K	0.84%	22
2023 Q2	$42.2M	Sell	313,039 -2,016	-0.6%	-$296K	0.74%	26
2023 Q1	$50.2M	Sell	315,055 -4,082	-1%	-$624K	0.93%	21
2022 Q4	$51.6M	Sell	319,137 -1,691	-0.5%	-$259K	1%	18
2022 Q3	$43.1M	Sell	320,828 -46	-0%	-$6.6K	0.93%	19
2022 Q2	$49.1M	Sell	320,874 -10,435	-3%	-$1.59M	1.04%	18
2022 Q1	$53.7M	Sell	331,309 -18,289	-5%	-$2.66M	0.96%	16
2021 Q4	$47.3M	Sell	349,598 -11,634	-3%	-$1.37M	0.78%	23
2021 Q3	$39M	Sell	361,232 -682	-0.2%	-$77.9K	0.69%	25
2021 Q2	$40.8M	Buy	361,914 +18,241	+5%	+$2.05M	0.79%	20
2021 Q1	$37.2M	Buy	343,673 +7,367	+2%	+$788K	0.75%	26
2020 Q4	$36M	Buy	336,306 +10,158	+3%	+$976K	0.75%	25
2020 Q3	$28.6M	Buy	326,148 +10,212	+3%	+$961K	0.67%	28
2020 Q2	$31M	Buy	315,936 +11,825	+4%	+$1.04M	0.77%	27
2020 Q1	$23.2M	Buy	304,111 +5,128	+2%	+$437K	0.67%	33
2019 Q4	$26.5M	Buy	298,983 +5,445	+2%	+$452K	0.62%	39
2019 Q3	$22.2M	Buy	293,538 +2,486	+0.9%	+$170K	0.56%	43
2019 Q2	$21.2M	Buy	291,052 +5,806	+2%	+$456K	0.56%	43
2019 Q1	$23M	Sell	285,246 -9,706	-3%	-$794K	0.62%	42
2018 Q4	$27.2M	Sell	294,952 -5,326	-2%	-$468K	0.83%	28
2018 Q3	$28.4M	Sell	300,278 -9,397	-3%	-$891K	0.8%	29
2018 Q2	$28.7M	Sell	309,675 -9,473	-3%	-$925K	0.87%	27
2018 Q1	$30.2M	Sell	319,148 -4,877	-2%	-$536K	0.93%	25
2017 Q4	$31.3M	Sell	324,025 -1,323	-0.4%	-$125K	0.93%	26
2017 Q3	$28.9M	Buy	325,348 +3,395	+1%	+$258K	0.89%	31
2017 Q2	$23.3M	Buy	321,953 +10,113	+3%	+$680K	0.72%	42
2017 Q1	$20.3M	Sell	311,840 -6,594	-2%	-$415K	0.62%	44
2016 Q4	$19.9M	Sell	318,434 -7,726	-2%	-$472K	0.65%	46
2016 Q3	$20.6M	Sell	326,160 -1,344	-0.4%	-$87K	0.7%	41
2016 Q2	$20.3M	Sell	327,504 -4,072	-1%	-$248K	0.71%	38
2016 Q1	$18.9M	Buy	331,576 +20,695	+7%	+$1.15M	0.67%	40
2015 Q4	$18.4M	Sell	310,881 -4,541	-1%	-$262K	0.78%	41
2015 Q3	$17.2M	Sell	315,422 -6,392	-2%	-$416K	0.77%	42
2015 Q2	$21.6M	Sell	321,814 -3,761	-1%	-$246K	0.9%	34
2015 Q1	$19.1M	Sell	325,575 -10,095	-3%	-$610K	0.79%	41
2014 Q4	$22M	Sell	335,670 -6,911	-2%	-$436K	0.92%	35
2014 Q3	$19.8M	Sell	342,581 -26,618	-7%	-$1.48M	0.87%	36
2014 Q2	$20.8M	Sell	369,199 -10,946	-3%	-$574K	0.89%	37
2014 Q1	$19.5M	Sell	380,145 -4,303	-1%	-$217K	0.86%	38
2013 Q4	$20.3M	Sell	384,448 -9,417	-2%	-$463K	0.9%	32
2013 Q3	$17.6M	Sell	393,865 -12,879	-3%	-$571K	0.81%	37
2013 Q2	$16.8M	Buy	+406,744	New	+$17.8M	0.78%	41

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fiduciary Trust's ABBV Position: Q1 2026 in Review

Fiduciary Trust reduced its AbbVie (ABBV) stake by 4.7% in Q1 2026, selling an estimated $3.4M and leaving 311,267 shares worth $67.7M. The position accounts for 0.8% of the portfolio, ranked #23.

Fiduciary Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $76.5M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Fiduciary Trust held 311,267 shares of AbbVie worth $67.7M as of Q1 2026.
Fiduciary Trust sold 15,340 AbbVie shares in Q1 2026, an estimated $3.4M.
AbbVie made up 0.8% of Fiduciary Trust's portfolio in Q1 2026, its #23 holding.
Fiduciary Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Fiduciary Trust's AbbVie position peaked at $76.5M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.